Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2003;16(3):204-9.
doi: 10.1046/j.1442-2050.2003.00329.x.

Treatment of Patients With Achalasia With Botulinum Toxin: A Multicenter Prospective Cohort Study

Affiliations
Clinical Trial

Treatment of Patients With Achalasia With Botulinum Toxin: A Multicenter Prospective Cohort Study

J Martínek et al. Dis Esophagus. .

Abstract

Botulinum toxin (BT) injection is an alternative treatment of achalasia. The aim of the study was to examine outcomes of patients treated with BT in the Czech Republic. Since 1997, 49 patients with achalasia have been treated with BT. We prospectively evaluated the effect of BT injection on 41 patients during a median follow-up of 24 months (range 9-62). Esophageal manometry was performed before and at 3-5 months after the injection. In 16 patients, BT was injected from the antegrade angle only (subgroup A), in 15 patients, BT was injected from both retrograde and antegrade angles (subgroup B) and, in 10 patients, BT injection was combined with subsequent balloon dilatation (subgroup C). Immediate clinical response was achieved in 93% of patients. Clinical remission was sustained beyond 3 months in 83% of patients (responders). Fourteen responders (41%) did not experience a relapse during the median of 22 months. Twenty responders (59%) experienced symptomatic relapse approximately 8 months after the injection. Ten relapsers underwent BT reinjection, five (50%) of them were asymptomatic for another 14 months. The remaining five (50%) patients reported a second relapse approximately 6 months after the reinjection. Median duration of the symptom-free period was 11.5 months after the first BT injection, and 10.5 months after the second (P = 0.21). We did not find any significant predictor of a favorable outcome; responders tended to be older and to have a lower basal lower-esophageal-sphincter pressure. Patients in subgroup C were more likely to be in remission at 1 and 2 years as compared with patients in subgroup A. BT injection is an effective treatment of achalasia in the short term. However, almost 70% of patients experience a relapse within 2 years. BT injection should therefore be reserved for patients at risk for more invasive procedures or for patients who prefer this treatment.

Similar articles

See all similar articles

Cited by 16 articles

  • 2019 Seoul Consensus on Esophageal Achalasia Guidelines.
    Jung HK, Hong SJ, Lee OY, Pandolfino J, Park H, Miwa H, Ghoshal UC, Mahadeva S, Oshima T, Chen M, Chua ASB, Cho YK, Lee TH, Min YW, Park CH, Kwon JG, Park MI, Jung K, Park JK, Jung KW, Lim HC, Jung DH, Kim DH, Lim CH, Moon HS, Park JH, Choi SC, Suzuki H, Patcharatrakul T, Wu JCY, Lee KJ, Tanaka S, Siah KTH, Park KS, Kim SE; Korean Society of Neurogastroenterology and Motility. Jung HK, et al. J Neurogastroenterol Motil. 2020 Apr 30;26(2):180-203. doi: 10.5056/jnm20014. J Neurogastroenterol Motil. 2020. PMID: 32235027 Free PMC article. Review.
  • Gentamicin submucosal lavage during peroral endoscopic myotomy (POEM): a retrospective analysis.
    Bayer J, Vackova Z, Svecova H, Stirand P, Spicak J, Martinek J. Bayer J, et al. Surg Endosc. 2018 Jan;32(1):300-306. doi: 10.1007/s00464-017-5677-8. Epub 2017 Jun 27. Surg Endosc. 2018. PMID: 28656335
  • Acute oesophageal symptoms.
    Hossain SM, de Caestecker J. Hossain SM, et al. Clin Med (Lond). 2015 Oct;15(5):477-81. doi: 10.7861/clinmedicine.15-5-477. Clin Med (Lond). 2015. PMID: 26430190 Free PMC article. Review.
  • Idiopathic (primary) achalasia: a review.
    Patel DA, Kim HP, Zifodya JS, Vaezi MF. Patel DA, et al. Orphanet J Rare Dis. 2015 Jul 22;10:89. doi: 10.1186/s13023-015-0302-1. Orphanet J Rare Dis. 2015. PMID: 26198208 Free PMC article. Review.
  • Treatment of gastrointestinal sphincters spasms with botulinum toxin A.
    Brisinda G, Sivestrini N, Bianco G, Maria G. Brisinda G, et al. Toxins (Basel). 2015 May 29;7(6):1882-916. doi: 10.3390/toxins7061882. Toxins (Basel). 2015. PMID: 26035487 Free PMC article. Review.
See all "Cited by" articles

Substances

Feedback